Surgical Wound Care & Dehiscence: ICD-10 Codes (T81.31), Prevention & Evidence-Based Management
Share
Understanding the Phases of Surgical Wound Healing
Optimal post-operative wound care requires understanding the four overlapping phases of wound healing:
Phase 1: Haemostasis (0 to several hours post-surgery)
Immediately after tissue injury, vasoconstriction occurs, followed by platelet aggregation and activation of the coagulation cascade. A fibrin clot forms, providing a provisional matrix and scaffold for subsequent healing. This phase is largely completed by the time the patient returns to the ward.
Phase 2: Inflammation (days 1–4)
Vasodilation and increased capillary permeability facilitate neutrophil and macrophage recruitment. Neutrophils perform initial debridement (removal of bacteria and devitalised tissue). Macrophages orchestrate the transition to proliferation by releasing growth factors (VEGF, PDGF, TGF-beta). Clinical signs of normal inflammation (redness, warmth, swelling, pain) are expected in the first 3–5 days post-operatively and should be distinguished from SSI.
Phase 3: Proliferation (days 4–21)
Fibroblasts migrate into the wound and synthesise collagen (initially Type III, later replaced by Type I). Granulation tissue (fibroblasts, new capillaries in a collagen matrix) fills the wound bed. Myofibroblasts contract the wound edges. Keratinocytes proliferate from wound margins to re-epithelialise. This phase is the critical window for appropriate dressing selection and wound bed preparation.
Phase 4: Remodelling (weeks to months)
Collagen is reorganised from Type III to Type I and cross-linked, increasing tensile strength. A mature scar reaches approximately 80% of original skin tensile strength — never 100%. Hypertrophic or keloid scarring occurs when collagen deposition is dysregulated. Silicone gel sheets and pressure garments are used for scar management at this stage.
ICD-10 Codes for Surgical Wound Complications
| ICD-10 Code | Description | Notes |
|---|---|---|
| T81.31XA | Disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter | Fascial dehiscence, anastomotic breakdown; A = initial encounter |
| T81.31XD | Disruption of internal operation wound, subsequent encounter | D = subsequent encounter (ongoing management) |
| T81.32XA | Disruption of external operation (surgical) wound, not elsewhere classified, initial encounter | Skin/subcutaneous dehiscence; most commonly coded |
| T81.32XD | Disruption of external operation wound, subsequent encounter | Use for ongoing dressing clinic visits |
| T81.33XA | Disruption of traumatic injury wound repair, initial encounter | Trauma repair breakdown; distinct from surgical wound |
| T79.3XXA | Post-traumatic wound infection, initial encounter | Traumatic wound infection (not surgical) |
| T81.40XA | Infection following a procedure, unspecified, initial encounter | SSI not otherwise specified |
| T81.41XA | Infection following a procedure, superficial incisional surgical site, initial encounter | Corresponds to CDC superficial incisional SSI |
| T81.42XA | Infection following a procedure, deep incisional surgical site, initial encounter | Corresponds to CDC deep incisional SSI |
| T81.43XA | Infection following a procedure, organ and space surgical site, initial encounter | Corresponds to CDC organ/space SSI |
| Z48.00 | Encounter for change or removal of nonsurgical wound dressing | Use for outpatient/clinic wound dressing encounters |
| Z48.01 | Encounter for change or removal of surgical wound dressing | Standard post-operative dressing change encounter |
| Z48.02 | Encounter for removal of sutures | Suture/staple removal encounter |
CDC Classification of Surgical Site Infections (SSI)
The CDC (2017) SSI classification provides standardised definitions used by MOH Singapore for hospital surveillance and quality reporting:
| SSI Category | Tissue Depth | Timeframe | Diagnostic Criteria |
|---|---|---|---|
| Superficial Incisional SSI | Skin and subcutaneous tissue only | Within 30 days of surgery | Purulent drainage, positive culture, or clinician diagnosis of infection (pain, tenderness, localised swelling, redness, heat) |
| Deep Incisional SSI | Deep soft tissue (fascia, muscle) | Within 30 or 90 days (implant-related) | Purulent drainage from deep incision, spontaneous dehiscence, or deliberate opening; fever >38°C with localised pain |
| Organ/Space SSI | Organ or body cavity entered during surgery | Within 30 or 90 days | Purulent drainage from drain, positive culture of fluid/tissue from organ/space, imaging evidence of abscess |
What Are the Risk Factors for Wound Dehiscence?
Understanding modifiable and non-modifiable risk factors enables targeted prevention strategies:
Patient-Related Risk Factors
- Obesity (BMI >30): Increased wound tension, reduced tissue perfusion, impaired immune function; highest-risk single modifiable factor
- Diabetes mellitus: Hyperglycaemia impairs neutrophil function, collagen synthesis, and angiogenesis; peri-operative glycaemic control (target 6–10 mmol/L) reduces SSI risk
- Malnutrition: Protein deficiency impairs collagen synthesis; serum albumin <30 g/L is a strong predictor of dehiscence; optimise nutrition pre-operatively
- Smoking: Nicotine causes vasoconstriction, reducing tissue oxygenation; smoking cessation ≥4 weeks pre-operatively significantly reduces SSI risk
- Immunosuppression: Corticosteroids, chemotherapy, or biological agents (TNF inhibitors) impair healing; minimise where clinically possible
- Anaemia: Tissue hypoxia impairs all phases of wound healing
Surgical Risk Factors
- Emergency versus elective surgery: Emergency procedures carry 2–3× higher SSI risk
- Wound classification: Clean (lowest risk), clean-contaminated, contaminated, dirty/infected (highest risk)
- Prolonged operative time (risk increases after 1–2 hours)
- Haematoma or seroma formation: Fluid collections under incisions create infection risk
- Poor surgical technique: Excessive tension on closure, poor haemostasis, foreign body contamination
Management of Wound Dehiscence: Secondary Intention vs Reclosure
Secondary Intention Healing
Most superficial and deep incisional dehiscences without significant infection are managed by open wound healing (secondary intention). The wound is debrided of non-viable tissue, and the wound bed is maintained moist with appropriate dressings. Granulation proceeds from the wound base upward; contraction closes the wound over weeks to months depending on size.
Delayed Primary Closure
Contaminated or infected dehiscent wounds that have been debrided and treated with antibiotics for 4–5 days may be suitable for delayed primary closure (secondary suturing). This is used selectively for abdominal wound dehiscences where fascia remains intact.
Surgical Reclosure
Full-thickness dehiscence with fascial involvement (burst abdomen) requires urgent operative repair. Tension sutures (far-near-near-far or all-through retention sutures) are used for high-tension closures. Abdominal wound closure at SGH, NUH, TTSH, and CGH follows institutional protocols for complex abdominal reconstruction.
Negative Pressure Wound Therapy (NPWT) for Surgical Wounds
NPWT applies sub-atmospheric pressure (typically -80 to -125 mmHg) to the wound surface via a foam interface and sealed dressing, connected to a collection canister. Mechanisms of action include:
- Removal of excess exudate and reduction of oedema
- Stimulation of granulation tissue by mechanical cell deformation
- Wound edge approximation (macro-deformation)
- Reduction in wound volume and depth
- Reduction in wound bacterial load (evidence limited)
Cochrane evidence (Dumville et al. 2014) supports NPWT for promoting healing in open surgical wounds. Indications include: complex dehiscent wounds, post-sternotomy wounds, open abdominal wounds, post-orthopaedic surgical complications, and prophylactic incisional NPWT for high-risk closed incisions.
Contraindications: inadequately debrided wounds, malignancy in the wound bed, untreated osteomyelitis, active bleeding, and patients on anticoagulants (relative contraindication). NPWT devices are available at SGH, NUH, TTSH, Gleneagles Hospital, and Mount Elizabeth Hospital.
Antiseptic Wound Cleansing: Evidence and Recommendations
| Antiseptic | Indications | Evidence/Notes |
|---|---|---|
| Normal Saline (0.9%) | Reference standard for non-infected wounds; primary closure dressings | Non-cytotoxic; no antimicrobial effect; suitable for all phases |
| Prontosan (PHMB/betaine) | Biofilm disruption; critically colonised wounds; MRSA wounds | Polyhexanide + betaine surfactant; disrupts biofilm matrix; biocompatible at recommended concentrations |
| Chlorhexidine 0.05% | Wound irrigation; peri-wound skin antisepsis | Broad spectrum; avoid in middle ear wounds; cytotoxic at high concentrations (>0.5%) |
| Povidone-iodine (PVP-I) 10% | Skin antisepsis before surgical incision; infected wounds (short-term) | Cytotoxic to fibroblasts at full concentration; diluted 0.5% preparations preferred for open wounds; avoid in thyroid disease |
| Cadexomer Iodine | Infected/contaminated open wounds; biofilm-associated wounds | Slow-release iodine from starch microspheres; Cochrane evidence for benefit over standard care in infected VLUs and surgical wounds |
| Hypochlorous acid (HOCl) | Infected wounds; biofilm disruption | Biocompatible; broad-spectrum antimicrobial; emerging evidence base |
Dressing Selection for Post-Operative Wounds
- Island dressings (Primapore, Mepore): Standard for primarily closed surgical incisions; maintain for 24–48 hours post-operatively unless soaked or contaminated. Change if wet or lifted.
- Silicone border foam dressings: For fragile skin or patients at high risk of wound edge complications; gentle removal reduces trauma; can remain in situ for 5–7 days on clean wounds
- Hydrocolloid dressings: For superficial dehiscences with low exudate; autolytic debridement; change every 3–5 days or when seal is lost
- Foam dressings: For dehiscent wounds with moderate exudate; highly absorbent; available in cavity/rope forms for deep wounds
- Alginate dressings: For highly exudative open surgical wounds or haemostatic requirements in debrided cavities; moisten before removal if dry
- Antimicrobial dressings (silver, PHMB): For infected or critically colonised post-operative wounds; use for 2-week courses and reassess
- Transparent film dressings: For IV catheter sites, donor sites, and superficial abrasions; allow wound monitoring without removal
ERAS Protocols and Surgical Site Infection Prevention in Singapore
Enhanced Recovery After Surgery (ERAS) protocols, now standard at SGH, NUH, TTSH, and KKH, include multiple evidence-based interventions that reduce SSI risk and optimise wound healing:
- Pre-operative carbohydrate loading (reduces catabolic stress)
- Chlorhexidine-alcohol skin antisepsis (superior to aqueous iodine for SSI prevention per NICE NG125 2019)
- Peri-operative normothermia (hypothermia impairs immune function and wound healing)
- Peri-operative glycaemic control (target 6–10 mmol/L)
- Antibiotic prophylaxis within 60 minutes of incision (specific to wound class)
- Early mobilisation (improves tissue perfusion)
- Minimally invasive surgical approaches where appropriate
MOH Singapore mandates SSI surveillance for specific procedure categories as part of the National Healthcare Quality Improvement Programme (NHQIP). Hospitals report SSI rates for colorectal, joint replacement, and caesarean section procedures.
Frequently Asked Questions About Surgical Wound Care
When should a post-operative wound dressing be first changed?
NICE NG125 (2019) recommends that post-operative dressings for primarily closed wounds should not be routinely changed until 48 hours post-operatively, as the undisturbed wound environment supports epithelialisation. After 48 hours, dressings should be changed when wet, soiled, or lifted, or at the first post-operative visit. Patients may shower after 48 hours if the wound is covered with a waterproof dressing.
How should a wound with suspected dehiscence be assessed urgently?
Assess wound separation depth (superficial skin only vs fascial involvement), presence of bowel/organ protrusion (evisceration requires immediate emergency surgical review), presence of infection (erythema, purulence, fever), and wound edge viability. Take a wound swab before starting antibiotics. Photograph and document the wound dimensions. Contact the surgical team immediately for deep dehiscence or any suspicion of fascial disruption.
What dressing is recommended for a post-laparotomy wound healing by secondary intention?
For open abdominal wounds healing by secondary intention, foam cavity dressings or alginate rope for deep wounds with high exudate, changed daily or every 2 days. NPWT (VAC therapy) is highly effective for accelerating granulation in large open abdominal wounds and is recommended for wounds with depth >2 cm or those not progressing adequately with conventional dressings. Review dressing choice weekly based on wound progress.
EMIS+ supplies evidence-based wound care dressings across Singapore. Browse our wound care range at emis.asia or contact our nursing team for product advice.
References
- Berrios-Torres SI, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784–791.
- NICE. Surgical site infections: prevention and treatment (NG125). London: NICE, 2019.
- Dumville JC, et al. Negative pressure wound therapy for treating surgical wounds healing by secondary intention. Cochrane Database Syst Rev. 2014;1:CD011278.
- Dumville JC, et al. Postoperative wound dressings and topical agents for preventing surgical site infection. Cochrane Database Syst Rev. 2016;9:CD011420.
- NICE. Acutely ill adults in hospital: recognising and responding to deterioration (CG50). London: NICE, 2007.
- Leaper DJ, et al. EWMA document: Antimicrobials and non-healing wounds. J Wound Care. 2012;21(3 Suppl):S1–S89.
- Weiland DE. Wound healing after colectomy: a review of the evidence. Clin Colon Rectal Surg. 2006.
- World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection. Geneva: WHO, 2016.